PATENT CLAIM ANALYSIS

Application Number: 15965406
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "565000"]

Abstract:
Methods of suppressing cyclooxygenase activity or reducing platelet aggregation of a mammal in need thereof by administering to a mammal in need thereof an effective amount of trans-resveratrol and arginine for a period of at least two weeks.

Claim (Index 16):
The method according to  claim 13 , wherein the effective amount of trans-resveratrol and arginine conjugate is 50 mg to 900 mg daily.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 91.0
- Lexical Diversity: 1.3
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14924715', '14924717', '15694675', '14655052', '14740410']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8083667034420776
- 35 USC 102 Novelty (BERT): 0.6486378892551059
- Combined Prediction Score: 0.7923938220233805
- Mean Citation Score: 501.93231599999984
- Max Citation Score: 704.3647
- Similarity Product: 552.5033251397609

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test